Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways-Reference-Cited by-同舟云学术

Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways

Published:2022-05 Issue: Volume:359 Page:109916
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Siraj Md Afjalus,Jacobs Aaron T.^ORCID,Tan Ghee T.^ORCID

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference125 articles.

1. Cancer statistics, 2020;Siegel;CA: A Cancer J. Clin.,2020

2. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status;Howlader;JNCI: J. Natl. Cancer Inst.,2014

3. Use of complementary and alternative medicine among young patients with breast cancer;Hammersen;Breast Care,2020

4. Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study;Neuhouser;Breast Cancer Res. Treat.,2016

5. Complementary and alternative medicine use among women with breast cancer: a systematic review;Wanchai;Clin. J. Oncol. Nurs.,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer;Antioxidants;2024-06-06

2. Fungal metabolite altersolanol a exhibits potent cytotoxicity against human placental trophoblasts in vitro via mitochondria-mediated apoptosis;Mycotoxin Research;2024-05-08

3. Enhanced efficacy of β-carotene loaded solid lipid nanoparticles optimized and developed via central composite design on breast cancer cell lines;Heliyon;2024-04

4. Metabolites from Fungi: A Promising Source of Lead Compounds Against Cancer;Fungi Bioactive Metabolites;2024

5. The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer;Biochemia medica;2023-10-13